Lohocla Research Announces FDA Clearance of Investigational New Drug Application for Kindolor, a Novel Medicinal Molecule for Treating Chronic Pain

Focusing on non-addictive treatments for chronic pain and addiction, Lohocla Research Corporation gets the go-ahead for first-in-human trials of their first-in-class therapeutic for chronic pain syndromes.